Market closedADR

Dr. Reddy's Laboratories/$RDY

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Dr. Reddy's Laboratories

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Ticker

$RDY

Trading on

NYSE

Industry

Pharmaceuticals

Headquarters

Hyderabad, India

Employees

27,048

RDY Metrics

BasicAdvanced
$12B
Market cap
19.51
P/E ratio
$0.76
EPS
0.33
Beta
$0.08
Dividend rate
0.55%
Dividend yield
$12B
0.33
$84.46
$14.52
251K
$0.08
1.919
1.172
2.38
15.694
12.49%
28.89%
10.10%
19.27%
19.508
3.464
3.45
5.22
117.648
0.55%
0.55%
12.37%
4.63%
13.81%
39.83%
16.96%

What the Analysts think about RDY

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Dr. Reddy's Laboratories stock.

RDY Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

RDY Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $RDY

$

Sign up or log in to buy
Capital at risk
Market closedADR

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Dr. Reddy's Laboratories stock?

Dr. Reddy's Laboratories (RDY) has a market cap of $12B as of November 14, 2024.

What is the P/E ratio for Dr. Reddy's Laboratories stock?

The price to earnings (P/E) ratio for Dr. Reddy's Laboratories (RDY) stock is 19.51 as of November 14, 2024.

Does Dr. Reddy's Laboratories stock pay dividends?

Yes, the Dr. Reddy's Laboratories (RDY) stock pays dividends to shareholders. As of November 14, 2024, the dividend rate is $0.08083 and the yield is 0.55%. Dr. Reddy's Laboratories has a payout ratio of 12.49% on a trailing twelve-month basis.

When is the next Dr. Reddy's Laboratories dividend payment date?

The next Dr. Reddy's Laboratories (RDY) dividend payment date is unconfirmed.

What is the beta indicator for Dr. Reddy's Laboratories?

Dr. Reddy's Laboratories (RDY) has a beta rating of 0.33. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.